Navigation Links
2-year results: Artificial disc a viable alternative to fusion for 2-level disc disease
Date:5/20/2011

LOS ANGELES (May 20, 2011) When two adjacent discs in the low back wear out, become compressed and cause unmanageable pain, numbness or other symptoms, replacement with artificial discs can be a viable alternative to standard fusion surgery, based on two-year post-surgery data from a randomized, multicenter trial recently published in the Journal of Bone and Joint Surgery.

Previous studies have compared single-disc replacement with fusion but this is believed the first to evaluate the two forms of treatment for two contiguous discs, said Rick B. Delamarter, MD, vice chair for Spine Services in the Department of Surgery and co-medical director of the Spine Center at Cedars-Sinai Medical Center. He is the article's first author.

As part of the approval process for a specific artificial disc (the ProDisc-L), the study was designed to meet Food and Drug Administration criteria comparing overall results from a disc replacement patient group with those of a fusion group. Those comparisons found the two therapies comparable in terms of outcomes deemed favorable, but Delamarter said individual patient outcomes suggest the disc replacement operation may have advantages.

"Overall, 24 months after surgery, patients in both groups had less pain and were able to reduce their use of medication, but the percentages were higher in the disc replacement group. Seventy-three percent of disc replacement patients met the study's pain improvement criteria, compared with less than 60 percent of the fusion patients. Of these, only 19 percent in the disc replacement group continued to need narcotics for pain, compared with 40 percent in the fusion group. Also, more disc replacement patients said they were satisfied with their outcomes and would choose to have the surgery again," Delamarter said.

The article reported that disc replacement operations were quicker and resulted in less blood loss, hospital stays were shorter and patients experie
'/>"/>

Contact: Sandy Van
sandy@prpacific.com
808-526-1708
Cedars-Sinai Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. C-Sections Continue 12-Year Climb: U.S. Report
2. Transplant drug 2-year study outcomes show superior kidney function
3. First symptoms of psychosis evident in 12-year-olds
4. Law Firm Dussault and Zatir Settles Lawsuit Involving 92-Year-Old Woman Knocked Down by Neighbor's Dog
5. Abbreviated Trials Yield Misleading Results: Study
6. Artificial tissue promotes skin growth in wounds
7. Latest Artificial Pancreas Trials Reduce Risk of Low Blood Sugar
8. University of Granada researchers make the first bioartificial organ in Spain
9. For back, neck pain, artificial disc replacement has cost, outcome advantages over fusion surgery
10. Biological joints could replace artificial joints soon
11. Artificial Turf Helps Football Players With Agility Drills
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... With Memorial Day Weekend upon us, cookout season has officially ... to help prevent grill fires throughout the spring and summer. ... that gas grills led to an average of 7,100 home ... meanwhile, caused approximately 1,200 home fires per year during that ... the following tips from the NFPA to help protect your ...
(Date:5/24/2013)... E-Dentists.com has announced the launch of ... Media Surge, a leading medical Internet marketing agency. ... service will focus on providing dentists the help they ... their competitive keywords. The dental SEO analysis covers a ... on what their competitors are doing right. The goal ...
(Date:5/24/2013)... Drugs commonly used to treat glaucoma may cause droopy ... vision, according to a new study. The drugs, ... reduce eye pressure, have already been shown to cause ... researchers said, suggesting that the new findings could lead ... be conservative when prescribing these drugs, the researchers added, ...
(Date:5/24/2013)... researchers failed to replicate what appeared to be breakthrough ... they were published last year in the journal ... 2012, suggested that the drug bexarotene (marketed as Targretin) ... (Aβ) a pathological hallmark of Alzheimer,s disease ... of the 2012 report, drug treatment quickly removed most ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 The nation’s ... involving Intuitive Surgical Inc.’s da Vinci Surgical System concluded ... records, a Washington State Court jury ruled in a ... training a surgeon who performed a da Vinci prostatectomy ... The patient’s family had alleged in their lawsuit that ...
Breaking Medicine News(10 mins):Health News:Don’t Get Burned: Five Grilling Tips from Amica Insurance 2Health News:Dental SEO Analysis Launched by E-Dentists.com in Partnership with JD Media Surge 2Health News:Common Glaucoma Drug May Cause Droopy Eyelids, Study Finds 2Health News:Multiple research teams unable to confirm high-profile Alzheimer's study 2Health News:Multiple research teams unable to confirm high-profile Alzheimer's study 3Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on Verdict in Nation’s First Trial Involving Alleged Da Vinci Complications 2Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on Verdict in Nation’s First Trial Involving Alleged Da Vinci Complications 3
... can detect non-small cell lung cancer (NSCLC) in very early ... test is highly accurate// and has successfully detected cancer nodules ... ,The University has now decided to partner with ... detect lung cancer in smokers as well as in other ...
... Australia’s Townsville will be revolutionized after a A$ 3 million ... (JCU).// A rural medical school has also been announced by ... clinic will cost A$ 3 million, and permit students to ... give them experience with regard medicine in remote and rural ...
... and Technology Committee has issued a warning that if a ... a severe shortage of food. // ,The ... on an international level and has asked the Government to ... arise. As staff continue to take leave and supermarket deliveries ...
... to Food science and consumer acceptance in Norway the ... do experts to cheese.// ,The food compared was ... expert dairy assessors. The rating was based on reaction ... was difference of opinion in both factions. As a ...
... well known how nutritional dense milk is so ... to develop valuable new products with nutraceutical, pharmaceutical ... initiated in The University of Queensland's Institute for ... company. Microbial Screening Technologies (MST) has teamed up ...
... from the Pennsylvania State University are trying to determine why ... zebra fish. The team led by Mark Shriver studied genes ... in their key gene plays a major role in determining ... Science, may not only help explain why people of European ...
Cached Medicine News:
(Date:5/24/2013)... LOS ANGELES , May 24, 2013  An ... gathered on Saturday, May 18, in Santa ... findings on new lung-sparing therapies for MPM, a rare ... and commonly affects the pleura, the lining of the ... Heart, Lung and Blood Institute, the 3rd Annual International ...
(Date:5/24/2013)...  Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL ) ... Deutsche Bank Health Care Conference to be held May ... Adrian Adams , Chief Executive Officer and ... Company and its product pipeline at 12:00 p.m. ET ... http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) The presentation will also ...
(Date:5/24/2013)... , May 24, 2013 The ... for systemic delivery of therapeutic agents has been receiving ... drug delivery showing significant promise. The crucial formulation considerations ... delivery device play a major role in the efficiency ... in the development of new formulation techniques and devices ...
Breaking Medicine Technology:International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 2International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 4Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2
... 9, 2008 /PRNewswire-FirstCall/ - Echo,Therapeutics (OTC Bulletin ... human feasibility study of the Prelude(TM) SkinPrep ... for its,Symphony(TM) tCGM System, a novel transdermal ... diabetes home use and hospital critical,care markets. ...
... The Association,for Professionals in Infection Control and Epidemiology ... of Albany, NY, has been named,the 2008 recipient ... the annual award to an infection prevention and ... DeMille, a pioneer,in infection control. The award will ...
Cached Medicine Technology:Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System 2Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System 3Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System 4Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System 5New York Infection Prevention Expert Named Recipient of Carole DeMille Award 2
... manual hemostasis analyzer that is ideal ... PTs, aPTTs, thrombins, fibrinogens and factor ... testing, this analyzer is small in ... time and labor saving benefits. Operation ...
... The STart benchtop coagulation ... of electro-mechanical clot detection. This ... icteric or other optically dense ... offers programmable and preprogrammed assays ...
... STA-R Evolution is a fully-automated, stand-alone ... total laboratory automation line. Clotting, chromogenic ... in random access mode. The system's ... high throughput and rapid processing of ...
The ACL 9000 together with an extensive test menu and superior technology is backed by high-quality service to keep the lab running efficiently....
Medicine Products: